相关实验视频

Updated: Jul 13, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

蛋白质遗传药物反应概况阐明了髓纤维化的可针对性漏洞

Mattheus H E Wildschut^1,2,3, Julien Mena¹, Cyril Dördelmann⁴

¹Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.

Nature communications

|October 12, 2023

概括

这项研究确定了针对骨髓纤维化,一种干细胞疾病的新药标. 研究人员发现,特定的突变,如卡尔雷蒂库林 (CALR),预测对某些疗法的反应,提供个性化的治疗方法.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

骨髓纤维化是一种影响造血干细胞的骨髓增殖性瘤.
患者往往具有JAK2或卡尔雷蒂库林 (CALR) 突变,治疗选择有限.

研究的目的:

为了整合菌纤维化患者的ex vivo药物反应和蛋白型数据.
发现有针对性的弱点,并指导个性化的治疗策略.

主要方法:

高内容成像和单细胞深度学习分析了患者血液中的药物敏感性.
活体药物反应数据与分子分析进行了整合.

主要成果:

CALR突变与对BET和HDAC抑制剂的敏感性相关,特别是在没有高Ras通路活性的情况下.
增殖特征 (MCM复合高) 表明疾病已晚期,对DNA复制和促生存药物的敏感性.
同胞性CALR突变导致内质网膜 (ER) 压力,表明对ER压力因子和未折叠蛋白反应抑制剂的敏感性.

结论:

综合分析显示,骨髓纤维化中有三个不同的可针对性的脆弱性.
这些发现为个性化骨髓纤维化治疗提供了一个分子驱动的路线图.

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...